Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
13
14
15
17
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
6
Medical Philippines 2020
2020-08-12 - 2020-08-14    
All Day
ABOUT MEDICAL PHILIPPINES 2020 The Philippines would once again be hosting The 5th Edition of Medical Exhibition featuring 3 events namely: Medical Philippines 2020, Dental [...]
Agriculture & Horticulture
2020-08-16 - 2020-12-17    
All Day
Agriculture Conference invites a common platform for Deans, Directors, Professors, Students, Research scholars and other participants including CEO, Consultant, Head of Management, Economist, Project Manager [...]
18 Aug
2020-08-18 - 2020-08-19    
9:00 am - 1:30 pm
The definitive event for senior claims executives It has never been more important for insurers to make claims the focal point of innovation, agility and [...]
Events on 2020-08-12
Medical Philippines 2020
12 Aug 20
Seashell Ln,
Events on 2020-08-16
Events on 2020-08-18
Articles

Jun 02 : EMR: A Balancing Act of Patient Safety, Privacy & Health Care Delivery

somerset medical center

With almost $35 billion appropriated in government incentives and additional funds spent in development by institutions, the concept of an electronic patient record (EPR) within integrated health information technology (HIT) systems has taken the United States by storm. However, the United Kingdom’s expensive struggle to implement a seamless EPR highlights the variety of pitfalls and unforeseen complications ranging from recognizing the importance of accurately assessing EPR-related patient risks to understanding the difficulties in the exchange of information across a gradient of distinct interfaces. Furthermore, the tenuous relationship between HIT implementation and patient outcomes in the short-term draws into question the value of EPR construction costs along with the ethical and privacy issues they create. Nonetheless, experts agree that with future software advances and physician familiarization, a robust HIT will be an important asset to patient autonomy, epidemiologic and clinical research, evidence-based error reduction and the potential for cost reduction. This article seeks to review the current status of this initiative and potential pitfalls that remain.

Source